FGF2 and neoplasm: Ribatti et al. [17] have demonstrated a significant correlation between melanoma progression, percentage of FGF-2-expressing tumor cells, and the number of mast cells which, in turn, secrete other angiogenic molecules, such as VEGF-A [15].